Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
HYPE3:BVMF
Hypera SA
R$22.66
0.00%
(0.00) 1D
Apr 23, 5:07:45 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for HYPE3...
Open
R$22.85
High
R$23.20
Low
R$22.52
Mkt. cap
15.98B
Avg. vol.
3.40M
Volume
1.48M
Dividend
3.85%
Quarterly dividend
R$0.22
Ex dividend date
Feb 9, 2026
P/E ratio
12.18
52-wk high
R$27.25
52-wk low
R$19.36
EPS
R$1.86
Shares outstanding
704.01M
No. of employees
11K
News stories
From sources across the web
Profile
Hypera Pharma is a Brazilian multinational pharmaceutical company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
About Hypera SA
CEO-
Employees10.6K
Founded2001
HeadquartersItaim Bibi, State of São Paulo, Brazil
SectorPharmaceutical industry
Last report
Mar 13, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
0.71/ (0.69 est.)BRL
+2.34%beat
Revenue / Estimate
2.24B/ (2.21B est.)BRL
+1.14%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.08B
2.15B
2.23B
2.24B
Cost of goods sold
570.64M
858.85M
865.21M
858.94M
Cost of revenue
570.64M
858.85M
865.21M
858.94M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
715.58M
663.84M
687.46M
728.46M
Operating expense
732.54M
649.05M
688.45M
728.74M
Total operating expenses
1.30B
1.51B
1.55B
1.59B
Operating income
-222.28M
646.03M
673.59M
649.38M
Other non operating income
-6.84M
-8.87M
-14.67M
-27.28M
EBT including unusual items
-421.24M
433.99M
448.11M
439.21M
EBT excluding unusual items
-418.64M
436.68M
452.42M
438.30M
Income tax expense
-282.42M
7.90M
-5.77M
-10.46M
Effective tax rate
67.04%
1.82%
-1.29%
-2.38%
Other operating expenses
16.96M
-14.78M
987.00K
283.00K
Net income
-139.95M
426.69M
457.64M
450.99M
Net profit margin
-12.95%
19.81%
20.55%
20.16%
Earnings per share
-0.22
0.68
0.72
0.71
Interest and investment income
49.86M
49.38M
69.23M
68.87M
Interest expense
-238.21M
-253.18M
-283.65M
-268.84M
Net interest expenses
-188.36M
-203.79M
-214.42M
-199.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
-171.81M
694.71M
728.99M
702.34M
Gain or loss from assets sale
-633.00K
-1.54M
-11.00K
-253.00K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more